Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
511-525 of 2992 results
BioNano and UCLA to study structural variations in human genetic pediatric disorders
By MDBR Staff Writer
Genome analysis tools provider BioNano Genomics has signed a research collaboration agreement with the University of California, Los Angeles (UCLA), to undertake research on the role of structural variations in human genetic pediatric disorders.
Diagnostics > In Vitro Diagnostics > News
Roche launches new cobas c 513 analyser
By MDBR Staff Writer
Roche announced that its new, dedicated high-throughput HbA1c testing solution, the cobas c 513 analyser, is now available for countries accepting the CE mark.
Diagnostics > In Vitro Diagnostics > News
Immunovia, OHSU collaborating on early detection test for pancreatic cancer
By MDBR Staff Writer
Immunovia and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer.
Diagnostics > In Vitro Diagnostics > News
Amoy Diagnostics and Illumina enter strategic collaboration for next-generation sequencing cancer diagnostics in China
By MDBR Staff Writer
Amoy Diagnostics announced a strategic collaboration to accelerate the adoption of precision medicine and targeted therapies in China.
Diagnostics > In Vitro Diagnostics > News
Merck and Pfizer partner with Dako to develop companion diagnostic test for avelumab
By MDBR Staff Writer
Merck and Pfizer have collaborated with Agilent Technologies firm Dako to develop a potential companion diagnostic test (CDx) for an investigational immune checkpoint inhibitor avelumab.
Diagnostics > In Vitro Diagnostics > News
Medtronic initiates global study of minimally invasive technology to aid lung cancer diagnosis
By MDBR Staff Writer
Medtronic's Minimally Invasive Therapies Group recently launched a 2,500-patient, international study to assess real-world impact of its superDimension navigation system.
Diagnostics > In Vitro Diagnostics > News
VolitionRx announces CE mark for NuQ blood assay for detection of colorectal cancer
By MDBR Staff Writer
VolitionRx announced that the company's first CE mark for its blood-based diagnostic assay, NuQX001S, for detection of colorectal cancer.
Diagnostics > In Vitro Diagnostics > News
MetaStat reveals prognostic study preliminary results of MetaSite Breast test
By MDBR Staff Writer
Molecular diagnostic firm MetaStat has revealed preliminary results from a study of MetaSite Breast test in patients with ER-positive, HER2-negative early stage invasive breast cancer.
Diagnostics > In Vitro Diagnostics > News
Nestlé, AC Immune to develop diagnostic test for Alzheimer’s disease
By MDBR Staff Writer
Biomedical research institute Nestlé Institute of Health Sciences (NIHS) has entered into a research collaboration agreement with biopharmaceutical firm AC Immune to develop a diagnostic test for Alzheimer’s disease (AD).
Diagnostics > In Vitro Diagnostics > News
GenomOncology, Thomas Jefferson Hospital developing multi-assay integrated cancer profiling system
By MDBR Staff Writer
Healthcare technology firm GenomOncology, along with US-based Thomas Jefferson University Hospital, is involved in developing an interpretation and reporting system for multi-assay cancer profiling.
Diagnostics > In Vitro Diagnostics > News
Study Demonstrates T2Candida Panel is more sensitive and rapid than blood vulture at identifying invasive infections
By MDBR Staff Writer
T2 Biosystems announced that data on its T2Candida Panel was presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the International Society of Chemotherapy (ICC) joint meeting in San Diego, US.
Diagnostics > In Vitro Diagnostics > News
Transgenomic, University of Melbourne partner for MX-ICP technology
By MDBR Staff Writer
Australia’s University of Melbourne has received a license from biotechnology firm Transgenomic to use its Multiplexed ICE COLD-PCR (MX-ICP) technology for several research and clinical applications.
Diagnostics > In Vitro Diagnostics > News
WuXi NextCODE to provide genome testing services to China’s Fudan Children's Hospital
By MDBR Staff Writer
Precision medicine firm WuXi NextCODE has entered into an agreement with Shanghai-based Children's Hospital of Fudan University (CHFU) to provide genomic testing capabilities for rare diseases in China.
Diagnostics > In Vitro Diagnostics > News
ERBA Diagnostics Mannheim acquires Lumora
By MDBR Staff Writer
ERBA Diagnostics Mannheim, a global in vitro diagnostics company, announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial markets.
Diagnostics > In Vitro Diagnostics > News
Biocept secures agreements with Stratose and Galaxy Health Network for its blood-based oncology diagnostic assays
By MDBR Staff Writer
Biocept, a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces additional agreements with preferred provider organizations (PPOs).
Diagnostics > In Vitro Diagnostics > News
511-525 of 2992 results